Table 3.
Pig number | Pair ID | Immune status | Virus challenge | Pre challenge antibody level | Post‐challenge antibody level (d.p.e. sampled) | Days post‐exposure | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ||||||
405 | 1 | Naïve | Intranasal | <20 | 320 (29) | 0 | 1246 | 1471 | 1010 | 5443 | 86 | 12 | 128 | 0 | 0 |
410 | 1 | Naïve | Intranasal | <20 | 160 (29) | 0 | 983 | 1543 | 481 | 2186 | 229 | 31 | 33 | 0 | 0 |
409 | 2 | Vaccinated | In contact | <20 | 320 (19) | 0 | 0 | 38 | 0 | 7·0 | 513 | 0 | 0 | 0 | 0 |
417 | 2 | Vaccinated | In contact | 20 | 2560 (19) | 0 | 0 | 13 | 0 | 46 | 611 | 29 | 3 | 0 | 12 |
401 | 3 | Vaccinated | In contact | 20 | 20 (7) | 0 | 0 | 1071 | 0 | 0 | 35 | 0 | |||
402 | 3 | Vaccinated | In contact | 20 | 20 (7) | 0 | 0 | 63 | 0 | 0 | 0 | 0 | |||
415 | 4 | Vaccinated | In contact | 40 | 40 (11.) | 0 | 0 | 10 | 0 | 21 | 0 | 0 | 0 | 0 | 0 |
416 | 4 | Vaccinated | In contact | 40 | 40 (11.) | 0 | 0 | 0 | 0 | 8 | 0 | 24 | 0 | 0 | 0 |
403 | 5 | Vaccinated | In contact | 80 | 80 (9) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
406 | 5 | Vaccinated | In contact | 160 | 160 (9) | 0 | 0 | 0 | 0 | 0 | 52 | 0 | 0 | 0 | |
412 | 6 | Naïve | In contact | <20 | 320 (12) | 0 | 0 | 0 | 2836 | 2100 | 1729 | 405 | 61 | 0 | 0 |
414 | 6 | Naïve | In contact | <20 | 320 (12) | 0 | 0 | 0 | 0 | 1386 | 786 | 117 | 421 | 0 | 0 |
400 | 7 | Naïve | In contact | <20 | 20 (8) | 0 | 0 | 0 | 0 | 127 | 46 | 0 | |||
413 | 7 | Naive | In contact | <20 | >20 | 0 | 0 | 0 | 63 | 76 | 0 | 0 |
Data presented as viral RNA copy number/μl swab extract. Shaded cells, no sample collected (pig euthanased).